REDWOOD CITY, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Maxygen, Inc. today announced that its presentation at the Rodman & Renshaw Techvest 7th Annual Healthcare Conference at the New York Palace Hotel in New York, New York, on Monday, November 7, 2005 will be webcast live and can be accessed by visiting the investor relations section of the Company’s website at www.maxygen.com.
The presentation will be given at 11:35 a.m. (ET) by Russell Howard, chief executive officer of Maxygen, who will provide an overview of the Company and its progress in key programs. A replay will be available on the Maxygen website approximately three hours after the presentation and will be archived for 30 days.
The presentation will include discussion of non-GAAP financial measures. Reconciliation of the non-GAAP financial measures to the most directly applicable GAAP measures can be found at www.maxygen.com under the “News- Financial Reconciliations” tab.
Maxygen, Inc., headquartered in Redwood City, California, is focused on the development of superior versions of validated major protein pharmaceuticals. Maxygen’s technologies bring together advances in molecular biology and protein modification to create novel biotechnology products. The Company has over 120 U.S. and foreign patents relating to its MolecularBreeding directed evolution platform.
Maxygen, Inc.
CONTACT: Jeannine Medeiros, Investor and Public Relations of Maxygen,+1-650-298-5853
Web site: http://www.maxygen.com/
